Clinical Trial Update: The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of dolutegravir on whole-body insulin sensitivity, lipid profile, and endocrine markers in healthy volunteers; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: HIV-1-infection on Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2025-12-02